Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...
Mallia Therapeutics & Northway Biotech partner to manufacture soluble CD83 protein for hair loss treatment: Erlangen, Germany Wednesday, February 5, 2025, 15:00 Hrs [IST] Mallia T ...
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug ...
The short answer is yes. Stress is considered an "initiating event" that contributes to hair loss. Learn how hair loss from stress happens in this article.